Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 7

Zeitschriftenartikel

Fey, Theres; Erickson, Nicole ORCID logoORCID: https://orcid.org/0000-0002-0473-7689; Stahler, Arndt; Muenchhoff, Maximilian; Keppler, Oliver T.; Rühlmann, Katharina; Krauss-Pfeiffer, Gabriele; Steinberg, Hannah; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Khatamzas, Elham; Seynstahl, Sarah; Casuscelli, Jozefina; Markwardt, Daniel; Forstpointner, Roswitha; Schinkoethe, Timo; Bergwelt-Baildon, Michael von und Heinemann, Volker (2022): Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV. In: Medical Oncology, Bd. 39, Nr. 6 [PDF, 678kB]

Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Hänel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschütz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmüller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael (2021): Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients. A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group. In: HemaSphere, Bd. 5, Nr. 7, e600

Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Haenel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschuetz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmueller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael (2021): Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hamatologie und Onkologie and the German Low-Grade Lymphoma Study Group. In: Hemasphere, Bd. 5, Nr. 7, e600

Hiddemann, Wolfgang; Barbui, Anna Maria; Canales, Miguel A.; Cannell, Paul K.; Collins, Graham P.; Dürig, Jan; Forstpointner, Roswitha; Herold, Michael; Hertzberg, Mark; Klanova, Magdalena; Radford, John; Seymour, John F.; Tobinai, Kensei; Trotman, Judith; Burciu, Alis; Fingerle-Rowson, Günter; Wolbers, Marcel; Nielsen, Tina und Marcus, Robert E. (2018): Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety. In: Journal of Clinical Oncology, Bd. 36, Nr. 23: S. 2395-2404 [PDF, 904kB]

Giessen, Clemens; Di Gioia, Dorit; Huber, Bruno; Seppi, Bettina; Graser, Anno; Duerr, Hans Roland; Mayr, Doris; Kirchner, Thomas; Rosenwald, Andreas; Forstpointner, Roswitha; Heinemann, Volker; Bogner, Johannes R. und Ostermann, Helmut (Februar 2012): Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant. In: Journal of clinical pathology, Bd. 65, Nr. 2: S. 189-90 [PDF, 530kB]

Christopeit, Maximilian; Lenz, Georg; Forstpointner, Roswitha; Bartelheim, Kerstin; Kuehnbach, Robert; Naujoks, Kurt und Schalhorn, Andreas (2008): Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma. In: Chemotherapy, Nr. 4: S. 309-314 [PDF, 154kB]

Forstpointner, Roswitha; Braunschweig, R.; Meissner, H.; Lang, N.; Kühl, M. und Schalhorn, Andreas (1999): Embolization in an adrenocortical carcinoma as palliative therapy. In: Onkologie, Nr. 6: S. 513-516 [PDF, 69kB]

Diese Liste wurde am Sat Mar 23 23:29:09 2024 CET erstellt.